Get the app
US › Healthcare

Rezolute Inc (RZLT)

US · Healthcare · Biotechnology

$3.58-8.21%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Net profit
$-20.5M
EPS
$-0.20
EPS estimate
$-0.14

EPS came in at -0.20 against a street estimate of -0.14 — a miss of 42.9%.

Key statistics

Market cap
$471.0M
Forward P/E
0.0
P/B
3.30
Book value
$1.04
EPS (TTM)
$-0.75
52-week high
$11.46
52-week low
$1.07
50-day MA
$4.46
200-day MA
$3.78
Beta
0.54

Analyst view

Analysts rate Rezolute Inc a strong buy (11 buy, 0 hold, 0 sell out of 11) with an average price target of $9.80.

Shareholding

Insiders
9.74%
Institutions
98.37%

Largest institutional holders

FundStake
Federated Hermes Inc13.43%
RA Capital Management, LLC9.77%
BlackRock Inc7.98%
Opaleye Management Inc6.51%
Balyasny Asset Management LLC4.82%
Vanguard Capital Management, LLC3.97%
Siren, L.L.C.3.44%
Jacobs Levy Equity Management, Inc.2.65%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Rezolute Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.